These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 19246078

  • 41. Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study.
    Marzo-Ortega H, McGonagle D, Jarrett S, Haugeberg G, Hensor E, O'connor P, Tan AL, Conaghan PG, Greenstein A, Emery P.
    Ann Rheum Dis; 2005 Nov; 64(11):1568-75. PubMed ID: 15829577
    [Abstract] [Full Text] [Related]

  • 42. Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis.
    Vis M, Nurmohamed MT, Wolbink G, Voskuyl AE, de Koning M, van de Stadt R, Twisk JW, Dijkmans BA, Lems WF.
    J Rheumatol; 2005 Feb; 32(2):252-5. PubMed ID: 15693084
    [Abstract] [Full Text] [Related]

  • 43. Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis.
    Braun J, Brandt J, Listing J, Zink A, Alten R, Burmester G, Gromnica-Ihle E, Kellner H, Schneider M, Sörensen H, Zeidler H, Sieper J.
    Ann Rheum Dis; 2005 Feb; 64(2):229-34. PubMed ID: 15388511
    [Abstract] [Full Text] [Related]

  • 44. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL, Watson KD, Silman AJ, Symmons DP, British Society for Rheumatology Biologics Register.
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [Abstract] [Full Text] [Related]

  • 45. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.
    Visvanathan S, Keenan GF, Baker DG, Levinson AI, Wagner CL.
    J Rheumatol; 2007 May; 34(5):952-7. PubMed ID: 17444589
    [Abstract] [Full Text] [Related]

  • 46. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y, Markovits D, Rozin A, Toledano K, Nahir AM, Balbir-Gurman A.
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [Abstract] [Full Text] [Related]

  • 47. Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab.
    Visvanathan S, Wagner C, Marini JC, Baker D, Gathany T, Han J, van der Heijde D, Braun J.
    Ann Rheum Dis; 2008 Apr; 67(4):511-7. PubMed ID: 17644552
    [Abstract] [Full Text] [Related]

  • 48. Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period.
    Braun J, Deodhar A, Dijkmans B, Geusens P, Sieper J, Williamson P, Xu W, Visvanathan S, Baker D, Goldstein N, van der Heijde D, Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group.
    Arthritis Rheum; 2008 Sep 15; 59(9):1270-8. PubMed ID: 18759257
    [Abstract] [Full Text] [Related]

  • 49. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
    Doyle MK, Rahman MU, Han C, Han J, Giles J, Bingham CO, Bathon J.
    Semin Arthritis Rheum; 2009 Oct 15; 39(2):123-31. PubMed ID: 18823645
    [Abstract] [Full Text] [Related]

  • 50. A double-blind, placebo-controlled trial of low dose infliximab in ankylosing spondylitis.
    Inman RD, Maksymowych WP, CANDLE Study Group.
    J Rheumatol; 2010 Jun 15; 37(6):1203-10. PubMed ID: 20231198
    [Abstract] [Full Text] [Related]

  • 51. Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response.
    Haraoui B, Cameron L, Ouellet M, White B.
    J Rheumatol; 2006 Jan 15; 33(1):31-6. PubMed ID: 16395747
    [Abstract] [Full Text] [Related]

  • 52. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F.
    Ann Rheum Dis; 2005 Feb 15; 64(2):299-302. PubMed ID: 15166003
    [Abstract] [Full Text] [Related]

  • 53. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.
    Arad U, Tzadok S, Amir S, Mandelboim M, Mendelson E, Wigler I, Sarbagil-Maman H, Paran D, Caspi D, Elkayam O.
    Vaccine; 2011 Feb 11; 29(8):1643-8. PubMed ID: 21211590
    [Abstract] [Full Text] [Related]

  • 54. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab.
    Brandt J, Haibel H, Cornely D, Golder W, Gonzalez J, Reddig J, Thriene W, Sieper J, Braun J.
    Arthritis Rheum; 2000 Jun 11; 43(6):1346-52. PubMed ID: 10857793
    [Abstract] [Full Text] [Related]

  • 55. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
    Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P.
    Rheumatology (Oxford); 2006 Jan 11; 45(1):106-11. PubMed ID: 16287919
    [Abstract] [Full Text] [Related]

  • 56. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
    Kaine JL, Kivitz AJ, Birbara C, Luo AY.
    J Rheumatol; 2007 Feb 11; 34(2):272-9. PubMed ID: 17304653
    [Abstract] [Full Text] [Related]

  • 57. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
    Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB.
    Semin Arthritis Rheum; 2004 Feb 11; 33(4):283-8. PubMed ID: 14978666
    [Abstract] [Full Text] [Related]

  • 58. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
    Adler S, Krivine A, Weix J, Rozenberg F, Launay O, Huesler J, Guillevin L, Villiger PM.
    Rheumatology (Oxford); 2012 Apr 11; 51(4):695-700. PubMed ID: 22171015
    [Abstract] [Full Text] [Related]

  • 59. The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination.
    Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, Rimmelzwaan GF, Kroon FP.
    Ann Rheum Dis; 2008 May 11; 67(5):713-6. PubMed ID: 17965123
    [Abstract] [Full Text] [Related]

  • 60. Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies.
    Angel K, Provan SA, Hammer HB, Mowinckel P, Kvien TK, Atar D.
    Fundam Clin Pharmacol; 2011 Aug 11; 25(4):511-7. PubMed ID: 20825487
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.